Regulatory Exclusivity: A Special Flavor of Sui Generis Scheme By leveraging the power of regulatory agencies rather than property rights, regulatory exclusivity recreates the economic benefits of IP using a meaningfully different mechanism.
Strategies for Mutual Preference Understanding the workings of preference sheets—known as ‘prefs,’ for short—is one of the most important skills a debater at the national circuit can master. Let's take a look behind the curtain.
Precedent Advantages and the Distinguish Counterplan In this post, we will talk about legal precedent advantages, look at how they help the aff diversify their impacts, and examine a powerful strategy—the Distinguish CP—which can help the neg respond.
Negative Generics and the Litigation DA In this post, we will talk about the litigation DA - a piece of offense that will form the core of many generic CP + DA strategies on the upcoming topic.
T—Must Strengthen Pre-Existing IP In this post, we will put the topicality argument about which we speculated in our earlier exploration of the topic into practice. This argument excludes cases which expand what is eligible for IP protection beyond currently covered subject matter.
Impact Survey—Practice #1 Time to practice! In the document attached, you’ll find three examples of the 1AC, 1NC, and 2AC on AI and disease impacts. Let's give a 2NC extension.
Impact Survey—Biotech, Pharma, and Disease One of the most popular impact areas on this topic has to do with innovation by pharmaceutical companies. This file will help you navigate the impact level of those debates.
Impact Survey—Artificial Intelligence Artificial intelligence is one of the most common impact areas on this year’s IP topic. The attached file will give you a jumping off point to respond to any AI-related argument; the post will provide a brief overview of core disagreements in the area.